信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01801 信达生物

已收盘 02-02 16:08:06

78.700

-2.400

-2.96%

最高81.600	最低77.800	成交量844.62万
今开81.000	昨收81.100	日振幅4.69%
总市值1,365亿	流通市值1,365亿	总股本17.35亿
成交额6.65亿	换手率0.49%	流通股本17.35亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"信达生物","latestPrice":78.7,"timestamp":1770019686003,"preClose":81.1,"halted":0,"volume":8446227,"delay":0,"changeRate":-0.029593094944512843,"floatShares":1735000000,"shares":1735000000,"eps":-0.06541822376868645,"marketStatus":"已收盘","change":-2.4,"latestTime":"02-02 16:08:06","open":81,"high":81.6,"low":77.8,"amount":665426438,"amplitude":0.046856,"askPrice":78.8,"askSize":10000,"bidPrice":78.7,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":0.759043107362107,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":5,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":81.1,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":0.98999,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.4661,"impliedVolPercentile":0.1446},"requestUrl":"/m/hq/s/01801","defaultTab":"news","newsList":[{"id":"2607025472","title":"AI重塑医药生产力，为何超六成医药企业拥抱钉钉？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025472","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607025472?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:43","pubTimestamp":1769737380,"startTime":"0","endTime":"0","summary":"以“AI重塑医药生产力”为主题的2026医药钉峰会日前在沪召开，共探人工智能技术如何驱动赋能医药行业。AI自动完成数据抓取、分析与预警，让人人皆可成为开发者，大幅提升了业务响应的敏捷性。此外，AI正成为药企全球化协同的基石。AI不再是遥远的技术概念，而是已经成为医药行业提质、增效、创新的核心驱动要素。随着AI技术产品持续完善、行业生态日益繁荣，一场以人工智能为核心的医药生产力革命，正从蓝图加速照进现实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0819121731.USD","LU0708995153.HKD","LU0235996351.USD","BK1588","LU2778985437.USD","LU0823041008.USD","LU0823413660.USD","LU1051768304.USD","LU0264606111.USD","LU0320764599.SGD","LU0441854154.USD","BK1521","LU0543330566.HKD","LU0873338254.USD","LU0611395673.USD","LU0979878070.USD","LU0675040207.SGD","LU0516423174.USD","LU0127658192.USD","LU1719994722.HKD","LU0054237671.USD","SG9999004220.SGD","LU1720050803.USD","LU0329678337.USD","LU2328871848.SGD","LU0856984785.SGD","LU1048484197.HKD","LU0455707207.USD","SG9999000459.SGD","LU0577902454.USD","LU0784639295.USD","BK1615","LU2242644610.SGD","LU1831875114.USD","LU0348735423.USD","BK1517","LU0762540952.USD","02157","LU0417516738.SGD","LU0823039010.USD","LU2399975544.HKD","LU0577902538.SGD","LU0588545730.USD","LU3063872942.SGD","LU0828237510.HKD","LU1642822792.SGD","LU0143863198.USD","LU0181495838.USD","LU1880383440.USD","BK1608","LU0130518102.USD","BK1583","LU0054450605.USD","BK1610","LU0359201885.HKD","01276","LU0163747925.USD","LU0541502299.USD","LU0314109678.HKD","LU1282651048.USD","LU0449515922.USD","LU0865486749.SGD","LU0868486357.SGD","IE00B3M56506.USD","LU1880398471.USD","LU0831103253.SGD","LU1504937902.USD","LU1044876610.USD","LU0345776255.USD","LU1242518931.SGD","LU1769817179.HKD","LU0011963245.USD","LU0320764755.SGD","LU1282649810.SGD","LU0823397103.USD","LU2125910500.SGD","LU0327786744.USD","SG9999001093.SGD","LU0348788117.USD","LU0348827113.USD","LU1969619763.USD","LU1224444064.USD","LU2045819591.USD","LU0594300419.USD","LU1196710864.SGD","LU1956131251.USD","LU0287142896.SGD","LU0214875030.USD","89988","LU0251144936.SGD","LU1044875133.USD","LU2097828714.EUR","LU1188198961.HKD","LU0821914370.USD","LU0708995583.HKD","IE00B0JY6N72.USD","LU1316542783.SGD","LU1808992512.USD","LU0469268626.HKD","LU0106959298.USD","LU0823413587.USD","LU0164872284.USD","SG9999000327.SGD","LU0320764243.SGD","LU0588545904.SGD","06127","IE0032431581.USD","IE00B0169N27.USD","LU0890818403.SGD","LU0862451837.USD","LU2152927971.USD","LU0348783662.USD","LU0607220059.USD","BK1591","LU0164865239.USD","BK1501","LU0502904849.HKD","LU0572940350.SGD","LU1044874839.SGD","LU1481107354.HKD","LU0128522744.USD","LU1048596156.SGD","SGXZ90724238.SGD","LU1770036033.HKD","LU0499858602.USD","LU0210526637.USD","LU0128522157.USD","LU0516422366.SGD","601607","LU0886674414.USD","LU0029874905.USD","LU0823038988.USD","LU0417516571.SGD","IE0003895053.USD","LU0048580855.USD","LU1993786604.SGD","LU1282649141.HKD","LU0456846285.SGD","LU1023057109.AUD","09988","LU0871576103.HKD","LU1048588211.SGD","LU2097828631.EUR","LU0608807946.USD","LU1328615791.USD","LU0828237940.HKD","LU0051755006.USD","LU1794554557.SGD","LU1655091459.SGD","SG9999006514.SGD","LU0254981946.USD","LU0516422952.EUR","LU0348805143.USD","BK1142","BABA","LU0315178854.USD","LU1720051108.HKD","LU0449509016.USD","LU0737861699.HKD","LU0531971595.HKD","02607","LU1439103000.SGD","LU0831093199.SGD","LU0456827905.SGD","IE00B5MMRT66.SGD","LU0672654166.SGD","LU0516423091.SGD","LU0737861772.HKD","LU1981816686.USD","LU0231483743.USD","LU1115378108.SGD","BK1586","LU0307460666.USD","IE00B543WZ88.USD","LU1303224171.USD","LU2293587155.HKD","LU0577902611.USD","LU2097828474.EUR","SG9999002828.SGD","LU0540923850.HKD","LU0651946864.USD","BK1589","SG9999002463.SGD","LU0132412106.USD","LU1323998911.USD","IE00BZ08YR35.GBP","LU0823040885.USD","LU0762542818.HKD","BK1249","LU2449936058.SGD","000538","LU1051769294.HKD","LU1807302812.USD","LU1960683339.HKD","HK0000320223.HKD","LU0348783233.USD","LU0819123356.HKD","SG9999001689.USD","IE00BPRC5H50.USD","LU0164880469.USD","LU0048597586.USD","LU1211504680.USD","LU0700851271.USD","LU0169518387.USD","LU0359201612.USD","LU0608807433.USD","LU1201861165.SGD","LU0516422440.USD","SG9999001051.SGD","LU0173614495.USD","LU0149721374.USD","LU0499858438.USD","LU0293314216.USD","LU0463099449.HKD","LU2097829019.USD","BK1161","LU2087589342.USD","LU0593848301.USD","LU2476274720.SGD","LU1880398554.USD","LU0359202008.SGD","IE00BMPRXN33.USD","SG9999006597.SGD","HK0000320264.USD","LU0648948544.HKD","LU0117844026.USD","LU0096374516.USD","LU1548497426.USD","BK1618","LU1720051017.SGD","LU0029875118.USD","BK1515","LU0589944569.HKD","LU1961090484.USD","LU0228659784.USD","LU1282651121.HKD","LU2257852520.SGD","IE0034224299.USD","LU0348825331.USD","LU0577902371.SGD","LU0117841782.USD","LU0630378429.USD","LU0049853897.USD","LU0823397285.USD","LU0197773160.USD","LU0384037296.USD","LU1515016050.SGD","SG9999001226.SGD","IE00BZ08YT58.USD","LU0196878994.USD","LU0143863784.USD","LU0345775950.USD","LU0228367735.SGD","LU0052750758.USD","SG9999002562.SGD","LU0084288322.USD","LU1242518857.USD","LU0165289439.USD","LU0197773673.USD","01801","600276","LU0634319403.HKD","LU1366334578.USD","LU0244354667.USD","LU0259732245.USD","IE00BZ08YS42.EUR","IE00BMPRXR70.SGD","LU0149534421.HKD","LU0328353924.USD","LU0642271901.SGD","BK1574","LU0261950983.USD","BK1584","LU1224709979.USD","HK0000306701.USD","SHPMY","LU0588545490.SGD","LU0326950275.SGD","LU0640798160.USD","LU0762541174.USD","LU1770034418.SGD","HBBD.SI","LU0791591158.USD","LU0488056044.USD","LU0047713382.USD","LU2488822045.USD","SG9999014674.SGD","LU0862451753.SGD","LU0543330483.HKD","BK1575","LU0651947912.USD","LU0791590937.USD","LU0588546209.SGD","LU0210527791.USD","LU0211977185.USD","LU0048388663.USD","LU0431992006.USD","LU1568876335.HKD","SG9999001903.USD","LU0823426308.USD","LU0630378692.HKD","LU0261947096.USD","LU1880383366.USD","LU0561508036.HKD","LU0140636845.USD","LU1251922891.USD","LU1769817096.USD","LU1810669033.SGD","LU0417516902.SGD","LU0039217434.USD","LU0823426480.USD","LU0370786039.SGD","LU0061477393.USD","LU0898667661.SGD","LU2125910849.SGD","LU0531970944.HKD","LU0594300179.USD","LU0329678170.USD","LU1366334651.USD","LU0348784397.USD","LU0572939691.SGD","HK0000306685.HKD","LU1868837565.USD","LU2097828805.USD","LU2039709279.SGD","LU2097828557.USD","LU0572944931.SGD","LU1328277881.USD","LU1568876251.USD","HK0000165453.HKD","LU1688375341.USD","LU0106259558.USD","LU0541501648.USD","LU0229945570.USD","LU1282649067.USD","LU2357305700.SGD","LU0605514214.HKD","603127","IE0008368304.USD","LU0072462343.USD","LU0130103400.USD","ALBmain","LU0106252389.USD","LU0043850808.USD","LU2476274308.USD","LU1813983027.USD","LU1868838027.USD","LU0650527681.SGD","BK1502","LU0315179316.USD","LU0477156797.USD","LU0396098781.USD","LU0577902298.EUR","LU0648000940.SGD"],"gpt_icon":1},{"id":"2607704090","title":"每日卖空追踪 | 信达生物 01月29日卖空量成交21.3万股，卖空比例为2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704090?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675426,"startTime":"0","endTime":"0","summary":"信达生物北京时间01月29日，跌2.42%，卖空量成交21.3万股，较上一交易日减少78.55%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163838a6bae132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163838a6bae132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","LU2097828805.USD","BK1589","LU2242644610.SGD","LU2097828557.USD","BK1161","LU0455707207.USD","BK1583","LU0502904849.HKD","LU2097828631.EUR","LU2097828714.EUR","LU2488822045.USD","LU2097828474.EUR","01801","LU2328871848.SGD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2607704774","title":"信达生物01月29日主力净流出1472.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704774?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:15","pubTimestamp":1769674545,"startTime":"0","endTime":"0","summary":"01月29日, 信达生物股价跌2.42%，报收82.50元，成交金额6.9亿元，换手率0.48%，振幅2.07%，量比0.84。信达生物今日主力资金净流出1472.3万元，上一交易日主力净流入3037.4万元。该股近5个交易日上涨2.03%，主力资金累计净流出5858.6万元；近20日主力资金累计净流入1.3亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162056a6bacdb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162056a6bacdb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","LU2097828714.EUR","LU1969619763.USD","LU2097828805.USD","LU2097828631.EUR","LU2097828474.EUR","HK0000165453.HKD","LU0502904849.HKD","BK1161","LU2242644610.SGD","LU2097828557.USD","BK1589","LU0455707207.USD","LU2328871848.SGD","LU2488822045.USD","BK1583"],"gpt_icon":0},{"id":"2607704071","title":"信达生物：双抗双毒素ADC新药获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704071","media":"求实药社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704071?lang=zh_cn&edition=full","pubTime":"2026-01-29 12:01","pubTimestamp":1769659279,"startTime":"0","endTime":"0","summary":"来源：药研网1月29日，CDE官网公示，信达生物一类新药IBI3028的临床试验申请获得批准，用于标准治疗失败的局部晚期、不可切除或转移性实体瘤。据公开资料显示，IBI3028是一款双抗双毒素抗体偶联药物。IBI3028基于信达生物自主研发的DuettX 双载荷 ADC 平台构建，创新性地将双特异性抗体与两种作用机制不同的细胞毒性载荷相结合。目前，IBI3028的具体靶点组合及毒素类型尚未完全披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129124216953ed9f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129124216953ed9f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828805.USD","HK0000165453.HKD","LU2097828631.EUR","BK1583","LU2097828474.EUR","LU2488822045.USD","LU1969619763.USD","01801","LU2097828557.USD","LU2328871848.SGD","LU2097828714.EUR","LU2242644610.SGD","BK1589","BK1161","LU0455707207.USD","LU0502904849.HKD"],"gpt_icon":0},{"id":"2606479639","title":"信达生物01月28日获主力加仓3037.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606479639","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606479639?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588131,"startTime":"0","endTime":"0","summary":"01月28日, 信达生物股价涨3.30%，报收84.55元，成交金额9.7亿元，换手率0.67%，振幅3.24%，量比1.21。信达生物今日主力资金净流入3037.4万元，上一交易日主力净流入881.4万元。|01月28日主力加仓幅度排名||#|股票简称|主力净额占比|#|中国新消费集团|6.04%|#|曼妠|4.88%|#|GBA集团|2.92%|#|...|...|#362|信达生物|0.02%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161859a45f7003&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161859a45f7003&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU2097828714.EUR","LU0455707207.USD","LU0502904849.HKD","LU2097828631.EUR","LU2242644610.SGD","LU2097828474.EUR","BK1161","LU1969619763.USD","LU2097828805.USD","LU2488822045.USD","01801","LU2328871848.SGD","BK1583","LU2097828557.USD","BK1589"],"gpt_icon":0},{"id":"2606768580","title":"港股异动 | 信达生物(01801)涨近3% IBI3003获美国FDA快速通道资格认定 治疗多发性骨髓瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2606768580","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606768580?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:12","pubTimestamp":1769566325,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，信达生物涨近3%，截至发稿，涨2.2%，报83.6港元，成交额2.04亿港元。消息面上，据信达生物官微消息，2026年1月27日，公司宣布其抗GPRC5D/BCMA/CD3三特异性抗体IBI3003获得美国食品和药物监督管理局授予快速通道资格，拟定适应症为接受过含一种蛋白酶体抑制剂、一种免疫调节药物及一种抗CD38单抗的至少四线治疗的复发或难治性多发性骨髓瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 信达生物(01801)涨近3% IBI3003获美国FDA快速通道资格认定 治疗多发性骨髓瘤","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0455707207.USD","HK0000165453.HKD","BK1583","BK1589","LU1969619763.USD","LU2097828474.EUR","LU2097828805.USD","LU2488822045.USD","01801","LU2328871848.SGD","BK1161","LU2097828714.EUR","LU2097828631.EUR","LU2242644610.SGD","LU0502904849.HKD","LU2097828557.USD"],"gpt_icon":0},{"id":"2606873255","title":"每日卖空追踪 | 信达生物 01月27日卖空量成交15.9万股，卖空比例为2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606873255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606873255?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502626,"startTime":"0","endTime":"0","summary":"信达生物北京时间01月27日，涨0.24%，卖空量成交15.9万股，较上一交易日减少83.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127163924a6b235e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127163924a6b235e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","LU2097828631.EUR","LU2242644610.SGD","LU2097828557.USD","01801","LU0502904849.HKD","LU2097828805.USD","LU2097828474.EUR","LU2097828714.EUR","LU1969619763.USD","LU2328871848.SGD","LU2488822045.USD","BK1589","HK0000165453.HKD","LU0455707207.USD"],"gpt_icon":0},{"id":"2606732552","title":"信达生物01月27日主力净流入881.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2606732552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606732552?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501714,"startTime":"0","endTime":"0","summary":"01月27日, 信达生物股价涨0.24%，报收81.85元，成交金额5.5亿元，换手率0.39%，振幅2.57%，量比0.67。信达生物今日主力资金净流入881.4万元，上一交易日主力净流出838.0万元。该股近5个交易日下跌0.84%，主力资金累计净流出1.5亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入5343.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161606a45b230e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161606a45b230e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","LU2097828557.USD","LU2242644610.SGD","LU2097828631.EUR","LU0502904849.HKD","LU2097828474.EUR","LU0455707207.USD","LU1969619763.USD","LU2328871848.SGD","LU2097828714.EUR","LU2097828805.USD","01801","LU2488822045.USD","BK1161","BK1589","BK1583"],"gpt_icon":0},{"id":"2606206727","title":"2025年中国创新药对外授权交易额超1300亿美元创纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206727","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606206727?lang=zh_cn&edition=full","pubTime":"2026-01-27 15:31","pubTimestamp":1769499062,"startTime":"0","endTime":"0","summary":"2025年，中国创新药对外授权交易总金额超过1300亿美元，交易数量逾150笔，占全球总量约40%，创下历史新高。阿斯利康在2025年3月初宣布25亿美元投资计划，涵盖三项BD交易及一笔收购。辉瑞与三生制药于2025年5月达成的交易刷新中国创新药出海首付款纪录，达12.5亿美元；礼来全部4笔交易均为技术平台合作，其中2笔涉及晶泰控股与英硅智能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","01276","01801","01093","01530","03696","BK1161","02509","02142","03692"],"gpt_icon":0},{"id":"2606272282","title":"华福证券：医药生物业新技术全面突破 战略看多中国创新出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2606272282","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606272282?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:01","pubTimestamp":1769482871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华福证券发布研报称，2025年中国创新药全球竞争力凸显，出海交易创新高，多家企业扭亏为盈。战略看多中国创新出海。华福证券主要观点如下：国内复盘：全球竞争力凸显，企业扭亏为盈+管线出海价值新高度2025创新药指数大涨，Biopharma和Biotech持仓比例显著提升，核心驱动因素是中国创新药全球竞争力凸显。创新药市场份额快速提升，肿瘤与免疫领域创新药份额超32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127110355a6b10694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02615","01093","06978","06955","HK0000165453.HKD","BK1161","BK1583","06938","01801","01672","06160","BK1593","BK1574","09606","01276","01530","02157","09926","02162","02096","09887"],"gpt_icon":0},{"id":"1175967548","title":"信达生物宣布Ibi3003（Gprc5d/Bcma/Cd3三特异性抗体）获美国FDA授予针对复发或难治性多发性骨髓瘤的快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1175967548","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175967548?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:02","pubTimestamp":1769472131,"startTime":"0","endTime":"0","summary":"信达生物宣布，其研发的Ibi3003（一种靶向Gprc5d/Bcma/Cd3的三特异性抗体）已获得美国食品药品监督管理局（FDA）授予的快速通道资格，用于治疗复发或难治性多发性骨髓瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU2097828557.USD","LU2242644610.SGD","LU2097828631.EUR","LU0502904849.HKD","LU2097828474.EUR","LU0455707207.USD","LU1969619763.USD","LU2328871848.SGD","LU2097828714.EUR","LU2097828805.USD","01801","LU2488822045.USD","BK1161","BK1589","BK1583"],"gpt_icon":0},{"id":"2606758216","title":"2025第十一届中国最具影响力医药企业百强榜发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758216","media":"江南时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606758216?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:16","pubTimestamp":1769418960,"startTime":"0","endTime":"0","summary":"2026年1月26日，由董事会网、亚布力智库联合主办的“2025第十一届中国最具影响力医药企业百强榜”正式揭晓。在医药产业从“规模扩张”向“创新驱动”转型的关键期，本届百强榜的发布具有多重行业价值，成为解读中国医药产业格局的重要窗口。从本届榜单不难看出，中国医药产业正呈现“创新集聚、分化加剧、区域协同”的发展趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126172516a456f932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","06821","00874","BK1161","01530","09939","01477","02315","BK1574","01801","06160","BK1191","02196","BK1515","03692","01276","02607","02615"],"gpt_icon":0},{"id":"2606327803","title":"每日卖空追踪 | 信达生物 01月26日卖空量成交45.3万股，卖空比例为5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606327803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606327803?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416225,"startTime":"0","endTime":"0","summary":"信达生物北京时间01月26日，跌2.45%，卖空量成交45.3万股，较上一交易日减少65.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163816a6ad74ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163816a6ad74ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0455707207.USD","LU2097828631.EUR","HK0000165453.HKD","LU2242644610.SGD","BK1583","LU1969619763.USD","01801","LU2488822045.USD","LU2097828714.EUR","BK1589","LU2097828474.EUR","LU2097828557.USD","LU2328871848.SGD","BK1161","LU0502904849.HKD","LU2097828805.USD"],"gpt_icon":0},{"id":"2606326296","title":"【券商聚焦】招银国际：创新药出海趋势长期将延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2606326296","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606326296?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:17","pubTimestamp":1769404672,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨9.2%，跑赢MSCI中国指数5.6%。展望2026年，创新药出海趋势长期将延续，该机构将重点关注已出海管线的临床进展与数据兑现的核心催化。年初多个创新药BD交易落地，中国创新药出海的趋势向好。该机构认为，中国企业对于临床前分子的转让或将谨慎，未来中国出海分子将大多在具备中国早期临床试验数据的基础上达成，以获得更高的交易价值。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973928","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","LU0516423091.SGD","LU0588546209.SGD","LU0456827905.SGD","LU0348767384.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU1807302812.USD","LU1969619763.USD","06978","LU2242644610.SGD","BK1576","02142","01801","159992","LU0359201612.USD","01877","LU1303224171.USD","LU0315179316.USD","LU1960683339.HKD","SG9999002463.SGD","IE00B5MMRT66.SGD","06160","IE00BZ08YT58.USD","LU0348784397.USD","06185","LU0348825331.USD","LU1226287529.USD","LU0051755006.USD","09995","LU2399975544.HKD","LU0516422440.USD","LU1242518931.SGD","LU1880383366.USD","LU1226287875.USD","LU3063872942.SGD","LU0043850808.USD","02616","LU0516422952.EUR","09926","BK1588","LU0708995583.HKD","02269","BK1500","LU0979878070.USD","SG9999002562.SGD","LU1794554557.SGD","LU0417516902.SGD","09688","01177"],"gpt_icon":0},{"id":"2606780812","title":"信达生物盘中异动 早盘大幅下挫3.05%报81.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606780812?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:52","pubTimestamp":1769395959,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘10时52分，信达生物股票出现波动，股价快速下跌3.05%。截至发稿，该股报81.150港元/股，成交量223.783万股，换手率0.13%，振幅3.58%。资金方面，该股资金流入5661.47万港元，流出1.06306亿港元。信达生物股票所在的药品行业中，整体跌幅为0.60%。其相关个股中，四环医药、九源基因、山东新华制药股份涨幅较大，振幅较大的相关个股有英硅智能、劲方医药-B、宝济药业-B，振幅分别为11.34%、10.07%、7.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610524097a357c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610524097a357c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828714.EUR","BK1161","LU1969619763.USD","LU2328871848.SGD","BK1583","LU0502904849.HKD","LU2488822045.USD","LU2097828557.USD","LU0455707207.USD","01801","HK0000165453.HKD","BK1589","LU2097828474.EUR","LU2097828805.USD","LU2097828631.EUR","LU2242644610.SGD"],"gpt_icon":0},{"id":"2606706257","title":"医药生物行业：基金持仓重回底部 建议持续加配医药底部资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2606706257","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606706257?lang=zh_cn&edition=full","pubTime":"2026-01-25 00:00","pubTimestamp":1769270400,"startTime":"0","endTime":"0","summary":"本周医药商业受商务部等9 部门联合印发关于促进药品零售行业高质量发展的意见表现强劲，前期涨幅较大的个股有所回调，医药板块整体表现分化。基金持仓重回底部，建议持续加配医药底部资产。扣除医药基金后医药板块低配2.28%，配置占比较2025Q3 下降0.89pp。本周沪深300 下跌0.62%，医药生物下跌0.39%，处于31 个一级子行业第27 位，本周医药商业、中药、医疗器械、生物制品分别上涨4.26%、0.89%、0.30%、0.07%，化学制药、医疗服务分别下跌1.11%、2.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260125211211a453ef97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260125211211a453ef97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","09939","06127","BK1574","BK1161","01801","BK1515"],"gpt_icon":0},{"id":"2605289295","title":"每日卖空追踪 | 信达生物 01月23日卖空量成交63.4万股，卖空比例为5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605289295","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605289295?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157024,"startTime":"0","endTime":"0","summary":"信达生物北京时间01月23日，涨2.83%，卖空量成交63.4万股，较上一交易日减少59.02%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163745a6a44aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163745a6a44aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0502904849.HKD","BK1589","LU2097828474.EUR","LU1969619763.USD","LU2097828805.USD","BK1161","LU2488822045.USD","01801","LU2097828557.USD","LU2242644610.SGD","LU0455707207.USD","LU2097828714.EUR","LU2097828631.EUR","HK0000165453.HKD","BK1583","LU2328871848.SGD"],"gpt_icon":0},{"id":"2605098894","title":"国内药企扎堆在美国开展临床试验，创新药全球化发展迈入新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2605098894","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605098894?lang=zh_cn&edition=full","pubTime":"2026-01-23 14:32","pubTimestamp":1769149970,"startTime":"0","endTime":"0","summary":"此次，在美国开展的临床试验，是 7MW4911 在美国患者中的头次人体研究，旨在评估其在晚期结直肠癌及其他晚期胃肠道肿瘤患者中的安全性、药代动力学与有效性。此前，该药也已在中国获批开展临床并完成头例患者给药。总的来说，2026 年国内药企密集布局美国临床试验，标志着中国创新药已进入全球化新阶段，正加速从 “跟随者” 向 “体系创新者” 跃迁。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123143716a6a3c8e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123143716a6a3c8e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","LU1770034418.SGD","BK1574","BK1583","01276","01801","BK1588","LU1303224171.USD","01093","LU1969619763.USD","06160","BK1161","LU1251922891.USD","LU0307460666.USD","LU1719994722.HKD","09995","LU0588546209.SGD","06978","BK1500"],"gpt_icon":0},{"id":"2605892932","title":"信达生物盘中异动 下午盘急速拉升3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605892932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605892932?lang=zh_cn&edition=full","pubTime":"2026-01-23 14:00","pubTimestamp":1769148039,"startTime":"0","endTime":"0","summary":"2026年01月23日下午盘14时00分，信达生物股票出现异动，股价急速上涨3.01%。截至发稿，该股报83.850港元/股，成交量678.233万股，换手率0.39%，振幅3.26%。机构评级方面，在所有23家参与评级的机构中，91%的券商给予买入建议，9%的券商给予持有建议，无券商给予卖出建议。信达生物股票所在的药品行业中，整体涨幅为0.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123140039a44cf954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123140039a44cf954&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01801","LU2097828557.USD","LU1969619763.USD","BK1589","BK1583","LU2097828714.EUR","LU2242644610.SGD","HK0000165453.HKD","BK1161","LU0455707207.USD","LU2097828631.EUR","LU2488822045.USD","LU0502904849.HKD","LU2328871848.SGD","LU2097828805.USD","LU2097828474.EUR"],"gpt_icon":0},{"id":"2604138006","title":"GLP-1内卷升级！信达“玛仕度肽注射液”& 诺和诺德 “CagriSema注射液”新临床获批！","url":"https://stock-news.laohu8.com/highlight/detail?id=2604138006","media":"新药社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604138006?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:54","pubTimestamp":1768816486,"startTime":"0","endTime":"0","summary":"今日，国家药品监督管理局药品审评中心显示，两款重磅的GLP-1类药再获新适应症临床，GLP-1赛道内卷再次升级：信达生物—玛仕度肽注射液：高血压合并超重/肥胖人群的血压控制。诺和诺德—CagriSema注射液：用于低热量饮食和增加体力活动的基础上，8至18岁以下儿童及青少年的长期体重管理。CagriSema注射液：全球首款复方制剂，突破青少年治疗瓶颈CagriSema是全球首款GLP-1受体激动剂与胰淀素类似物复方制剂，由诺和诺德研发，采用每周一次皮下注射给药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119195926a72c6366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119195926a72c6366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","BK4590","LU1093756168.USD","BK4585","BK4599","IE00BKVL7J92.USD","01801","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU0154236417.USD","BK4007","BK4532","BK4588","NVO"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.innoventbio.com","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.0636},{"period":"3month","weight":-0.0678},{"period":"6month","weight":-0.128},{"period":"1year","weight":1.4539},{"period":"ytd","weight":0.0636}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"信达生物制药是一家主要从事研发、生产及销售治疗肿瘤、心血管及代谢（CVM）、自身免疫及眼科等重大疾病创新药物的投资控股公司。药物形式包括单克隆抗体、多特异性抗体、免疫细胞因子、抗体偶联药物（ADC）、细胞治疗及小分子药物等。该公司的主要产品包括达伯舒（信迪利单抗注射液）、达攸同（贝伐珠单抗注射液）、苏立信（阿达木单抗注射液）、达伯华（利妥昔单抗注射液）、达伯坦（佩米替尼片）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.041076},{"month":2,"riseRate":0.714286,"avgChangeRate":0.11927},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.021767},{"month":4,"riseRate":0.714286,"avgChangeRate":0.040816},{"month":5,"riseRate":0.428571,"avgChangeRate":0.027398},{"month":6,"riseRate":0.714286,"avgChangeRate":0.139165},{"month":7,"riseRate":0.428571,"avgChangeRate":0.010056},{"month":8,"riseRate":0.714286,"avgChangeRate":0.000214},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032182},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.02286},{"month":11,"riseRate":0.625,"avgChangeRate":0.079172},{"month":12,"riseRate":0.375,"avgChangeRate":0.024026}],"exchange":"SEHK","name":"信达生物","nameEN":"INNOVENT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"信达生物,01801,信达生物股票,信达生物股票老虎,信达生物股票老虎国际,信达生物行情,信达生物股票行情,信达生物股价,信达生物股市,信达生物股票价格,信达生物股票交易,信达生物股票购买,信达生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"信达生物(01801)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供信达生物(01801)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}